133 related articles for article (PubMed ID: 23803734)
1. Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: the polycomb connection.
Ray D; Kwon SY; Ptasinska A; Bonifer C
Cell Cycle; 2013 Jul; 12(14):2159-60. PubMed ID: 23803734
[No Abstract] [Full Text] [Related]
2. Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression.
Ray D; Kwon SY; Tagoh H; Heidenreich O; Ptasinska A; Bonifer C
Blood; 2013 Aug; 122(5):759-69. PubMed ID: 23616623
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.
Walter K; Cockerill PN; Barlow R; Clarke D; Hoogenkamp M; Follows GA; Richards SJ; Cullen MJ; Bonifer C; Tagoh H
Oncogene; 2010 May; 29(20):2927-37. PubMed ID: 20208555
[TBL] [Abstract][Full Text] [Related]
4. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
[TBL] [Abstract][Full Text] [Related]
5. PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.
Tiacci E; Pileri S; Orleth A; Pacini R; Tabarrini A; Frenguelli F; Liso A; Diverio D; Lo-Coco F; Falini B
Cancer Res; 2004 Oct; 64(20):7399-404. PubMed ID: 15492262
[TBL] [Abstract][Full Text] [Related]
6. PAX5, NOTCH3, CBFB, and ACD drive an activated RAS pathway and monosomy 7 to B-ALL and AML in donor cell leukemia.
Assi R; Mahfouz R; Owen R; Gunthorpe M; Chehab FF; Bazarbachi A
Bone Marrow Transplant; 2019 Jul; 54(7):1124-1128. PubMed ID: 30532056
[No Abstract] [Full Text] [Related]
7. The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling.
Stoner SA; Liu KTH; Andrews ET; Liu M; Arimoto KI; Yan M; Davis AG; Weng S; Dow M; Xian S; DeKelver RC; Carter H; Zhang DE
Blood Cancer J; 2020 Feb; 10(2):16. PubMed ID: 32029705
[TBL] [Abstract][Full Text] [Related]
8. TRIB1 overexpression in acute myeloid leukemia.
Röthlisberger B; Heizmann M; Bargetzi MJ; Huber AR
Cancer Genet Cytogenet; 2007 Jul; 176(1):58-60. PubMed ID: 17574965
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of tumor suppressors in t(8:21)-containing AML.
Yang G; Khalaf W; van de Locht L; Jansen JH; van der Reijden BA; Müller-Tidow C; Delwel HR; Serve H; Clapp DW; Hiebert SW
Ann Hematol; 2004; 83 Suppl 1():S83. PubMed ID: 15124686
[TBL] [Abstract][Full Text] [Related]
10. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.
Matsuura S; Yan M; Lo MC; Ahn EY; Weng S; Dangoor D; Matin M; Higashi T; Feng GS; Zhang DE
Blood; 2012 Mar; 119(13):3155-63. PubMed ID: 22223820
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Trib2 by an E2F1-C/EBPα feedback loop in AML cell proliferation.
Rishi L; Hannon M; Salomè M; Hasemann M; Frank AK; Campos J; Timoney J; O'Connor C; Cahill MR; Porse B; Keeshan K
Blood; 2014 Apr; 123(15):2389-400. PubMed ID: 24516045
[TBL] [Abstract][Full Text] [Related]
12. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
[TBL] [Abstract][Full Text] [Related]
13. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of leukemogenesis induced by AML 1-MTG 8].
Kitabayashi I; Ohki M
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):26-32. PubMed ID: 10643332
[No Abstract] [Full Text] [Related]
15. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Pulikkan JA; Madera D; Xue L; Bradley P; Landrette SF; Kuo YH; Abbas S; Zhu LJ; Valk P; Castilla LH
Blood; 2012 Jul; 120(4):868-79. PubMed ID: 22613795
[TBL] [Abstract][Full Text] [Related]
16. N822 mutation of KIT gene was frequent in pediatric acute myeloid leukemia patients with t(8;21) in Japan: a study of the Japanese childhood AML cooperative study group.
Shimada A; Taki T; Kubota C; Itou T; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y;
Leukemia; 2007 Oct; 21(10):2218-9. PubMed ID: 17525721
[No Abstract] [Full Text] [Related]
17. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.
Yoshino S; Tanaka M; Sunami Y; Takahara T; Yamazaki Y; Homme M; Niibori-Nambu A; Osato M; Minami T; Ishihara K; Nakamura T
Leukemia; 2022 Feb; 36(2):558-561. PubMed ID: 34381180
[No Abstract] [Full Text] [Related]
18. C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice.
Wang YY; Zhao LJ; Wu CF; Liu P; Shi L; Liang Y; Xiong SM; Mi JQ; Chen Z; Ren R; Chen SJ
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2450-5. PubMed ID: 21262832
[TBL] [Abstract][Full Text] [Related]
19. ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.
Hartmann L; Dutta S; Opatz S; Vosberg S; Reiter K; Leubolt G; Metzeler KH; Herold T; Bamopoulos SA; Bräundl K; Zellmeier E; Ksienzyk B; Konstandin NP; Schneider S; Hopfner KP; Graf A; Krebs S; Blum H; Middeke JM; Stölzel F; Thiede C; Wolf S; Bohlander SK; Preiss C; Chen-Wichmann L; Wichmann C; Sauerland MC; Büchner T; Berdel WE; Wörmann BJ; Braess J; Hiddemann W; Spiekermann K; Greif PA
Nat Commun; 2016 Jun; 7():11733. PubMed ID: 27252013
[TBL] [Abstract][Full Text] [Related]
20. Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.
Ter Elst A; Ma B; Scherpen FJ; de Jonge HJ; Douwes J; Wierenga AT; Schuringa JJ; Kamps WA; de Bont ES
Cancer Res; 2011 Apr; 71(7):2761-71. PubMed ID: 21447743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
